Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
21.15
-2.86 (-11.91%)
At close: Mar 18, 2026, 4:00 PM EDT
21.15
0.00 (0.00%)
After-hours: Mar 18, 2026, 5:28 PM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.27 billion as of March 18, 2026. Its market cap has increased by 24,025.11% in one year.
Market Cap
1.27B
Enterprise Value
1.27B
1-Year Change
24,025.11%
Ranking
Category
Stock Price
$21.15
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.27B, an increase of 245.49%. That is a compound annual growth rate of 25.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 1.45B | 3,835.22% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Generate Biomedicines | 1.67B |
| Enliven Therapeutics | 1.66B |
| Vericel | 1.65B |
| Innoviva | 1.63B |
| Agios Pharmaceuticals | 1.63B |
| Iovance Biotherapeutics | 1.63B |
| Nanobiotix | 1.60B |
| Harmony Biosciences Holdings | 1.60B |